AQST vs. URA
AQST (Aquestive Therapeutics, Inc.) is a stock, while URA (Global X Uranium ETF) is Commodity Producers Equities fund tracking the Solactive Global Uranium & Nuclear Components Total Return Index. Over the past 5 years, AQST returned -0.29%/yr vs 18.77%/yr for URA. At a 0.24 correlation, their price movements are largely independent.
Performance
AQST vs. URA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AQST achieves a -35.45% return, which is significantly lower than URA's 6.53% return.
AQST
- 1D
- -0.95%
- 1M
- 0.97%
- YTD
- -35.45%
- 6M
- -32.85%
- 1Y
- 25.98%
- 3Y*
- 22.65%
- 5Y*
- -0.29%
- 10Y*
- —
URA
- 1D
- 1.54%
- 1M
- -14.61%
- YTD
- 6.53%
- 6M
- 3.57%
- 1Y
- 32.44%
- 3Y*
- 32.17%
- 5Y*
- 18.77%
- 10Y*
- 15.90%
AQST vs. URA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | -35.45% | 81.46% | 76.24% | 123.92% | -76.81% | -27.29% | -8.08% | -7.62% | -58.14% |
URA Global X Uranium ETF | 6.53% | 67.18% | -0.58% | 46.25% | -11.32% | 57.57% | 41.33% | -3.54% | -7.48% |
Correlation
The correlation between AQST and URA is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2018 | 0.24 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AQST vs. URA — Risk / Return Rank
AQST
URA
AQST vs. URA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aquestive Therapeutics, Inc. (AQST) and Global X Uranium ETF (URA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AQST | URA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.33 | ||
| Sortino ratioReturn per unit of downside risk | -0.09 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.14 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.43 | 1.04 | -0.60 |
| Martin ratioReturn relative to average drawdown | 0.81 | 2.30 | -1.49 |
Loading charts...
Drawdowns
AQST vs. URA - Drawdown Comparison
The maximum AQST drawdown since its inception was -96.68%, roughly equal to the maximum URA drawdown of -93.54%. Use the drawdown chart below to compare losses from any high point for AQST and URA.
Loading charts...
Drawdown Indicators
| AQST | URA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.68% | -93.54% | -3.14% |
Max Drawdown (1Y)Largest decline over 1 year | -60.61% | -31.48% | -29.13% |
Max Drawdown (3Y)Largest decline over 3 years | -63.55% | -37.81% | -25.74% |
Max Drawdown (5Y)Largest decline over 5 years | -90.11% | -37.90% | -52.21% |
Max Drawdown (10Y)Largest decline over 10 years | — | -61.45% | — |
Current DrawdownCurrent decline from peak | -78.01% | -48.34% | -29.67% |
Average DrawdownAverage peak-to-trough decline | -76.92% | -74.94% | -1.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 32.01% | 14.12% | +17.89% |
Volatility
AQST vs. URA - Volatility Comparison
Aquestive Therapeutics, Inc. (AQST) has a higher volatility of 21.51% compared to Global X Uranium ETF (URA) at 17.69%. This indicates that AQST's price experiences larger fluctuations and is considered to be riskier than URA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AQST | URA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.51% | 17.69% | +3.82% |
Volatility (6M)Calculated over the trailing 6-month period | 68.41% | 39.95% | +28.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 85.07% | 51.24% | +33.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 82.62% | 43.96% | +38.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 87.69% | 37.91% | +49.78% |
Dividends
AQST vs. URA - Dividend Comparison
AQST has not paid dividends to shareholders, while URA's dividend yield for the trailing twelve months is around 4.58%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
URA Global X Uranium ETF | 4.58% | 4.88% | 2.86% | 6.07% | 0.76% | 5.84% | 1.69% | 1.66% | 0.44% | 2.03% | 7.28% | 1.96% |
Frequently Asked Questions
AQST and URA have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AQST has higher volatility (21.51%) compared to URA (17.69%). In terms of maximum drawdown, AQST dropped -96.68% vs URA's -93.54%.
URA currently has the higher Sharpe Ratio (0.64 vs 0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AQST and URA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer